Invention Application
- Patent Title: Carbidopa And L-Dopa Prodrugs And Methods Of Use
- Patent Title (中): 卡比多巴和左旋多巴前体药物及其使用方法
-
Application No.: US15216009Application Date: 2016-07-21
-
Publication No.: US20160362431A1Publication Date: 2016-12-15
- Inventor: Benoit CARDINAL-DAVID , Vincent S. CHAN , Kassibla DEMPAH , Brian P. ENRIGHT , Rodger F. HENRY , Raimundo HO , Ye HUANG , Alexander D. HUTERS , Russell C. KLIX , Scott W. KRABBE , Philip R. KYM , Yanbin LAO , Xiaochun LOU , Sean E. MACKEY , Mark A. MATULENKO , Peter T. MAYER , Christopher P. MILLER , James STAMBULI , Eric A. VOIGHT , Zhi WANG , Geoff G. ZHANG , Valentino J. STELLA
- Applicant: AbbVie, Inc.
- Main IPC: C07F9/09
- IPC: C07F9/09 ; A61K31/661 ; A61K45/06 ; C07F9/06 ; A61K31/6615
Abstract:
The present disclosure relates to (a) carbidopa prodrugs, (b) pharmaceutical combinations and compositions comprising a carbidopa prodrug and/or an L-dopa prodrug, and (c) methods of treating Parkinson's disease and associated conditions comprising administering a carbidopa prodrug and an L-dopa prodrug to a subject with Parkinson's disease.
Information query
